Lutz Heinemann on Muck Rack

Lutz Heinemann

As seen in: Journal of Diabetes Science and Technology, Color Research & Application, Nature, Wiley, Wiley Online Library, BMJ Open Diabetes Research & Care, SAGE Publishing, Medscape, The Lancet, Healio, Diabetes Care Magazine and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lutz

Contact Lutz, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Diabetes “Trade Journals”: A Rather Heterogeneous Affair

|
By Lutz Heinemann
| SAGE Publishing
You are adding the following journal to your email alerts New content Journal of Diabetes Science and Technology Restricted access Article commentary First published online December 1, 2025 Lutz Heinemann, PhD https://orcid.org/0000-0003-2493-1304 View all authors and affiliations Abstract There are a plethora of medical journals, also for the diabetes indication. Only a limited number of these journals are listed in databases like PubMed.
Open in Who Shared Issue with article?

Überwachung und Warnung durch CGM-Systeme in der Hausarztpraxis wäre sinnvoll

|
By Nicole Finkenauer, Lutz Heinemann
| Medical Tribune Germany Verified
Dipl.-Med. Ingrid Dänschel: Wir haben einen G-BA-Beschluss vom 16. Juni 2016, der immer noch greift. Und da muss man sagen: Das ist negativer Lobbyismus. Der Beschluss besagt, dass Systeme zur kontinuierlichen Glukosemessung (CGM) ausschließlich von diabetologischen Schwerpunktpraxen verordnet werden dürfen.
Open in Who Shared Issue with article?

Barriers to adoption of biosimilar insulins in Europe: A mixed‐methods study

|
By Elif Car, Arnold G Vulto, Lutz Heinemann, Garm Habets
| Wiley Online Library Verified
1 INTRODUCTION In Europe, approximately 61 million individuals (one in 11 adults aged 20–79 years) are affected by diabetes, with projections indicating an increase to 69 million by 2045.1 Diabetes-related healthcare expenditure in Europe amounted to USD 189.3 billion in 2021, representing 19.6% of total global diabetes expenditure.1 The growing economic burden of diabetes, coupled with the high cost of insulin therapy, emphasizes the need for sustainable solutions to improve accessibility...
Open in Who Shared Issue with article?
See all 19 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified